Healthcare professionals warned not to use certain intravenous metronidazole, ondansetron, and ciprofloxacin due to potential contamination

- Add this to...
- Twitter
- Facebook
- Google Bookmarks
- LinkedIn

Healthcare professionals warned not to use certain intravenous metronidazole, ondansetron, and ciprofloxacin due to potential contamination

Published Date:

6/1/10

Series:

HAN ; 314

Language:

English

[PDF-611.60 KB]

Details:

Corporate Authors:

Centers for Disease Control and Prevention (U.S.) ; United States. Food and Drug Administration. ;

Description:

Tuesday, June 01, 2010, 10:25 EST (10:25 AM EST) CDCHAN-00314-2010-06-01-ADV-N The U.S. Food and Drug Administration (FDA) is alerting healthcare professionals not to use certain intravenous (IV) bags of metronidazole, ondansetron, and ciprofloxacin because of potential contamination. FDA has received reports of floating matter in IV bags manufactured by Claris Lifesciences Limited, in Ahmedabad, India. Microbiological analysis identified the matter in one of the bags as a Cladosporium mold. Molds of this type can cause infections in susceptible patients, such as immunocompromised individuals. At this time, FDA is not aware of any reports of injuries due to administration of these products. Affected products include any metronidazole, ondansetron, and ciprofloxacin manufactured by Claris Lifesciences Limited and sold under the following labels: Claris, Sagent Pharmaceuticals, Pfizer, West-Ward Pharmaceuticals

Subject:

[+]

Document Type:

HAN Health Advisory

Place as Subject:

United States

Collection(s):

Health Alert Network (HAN)

Main Document Checksum:

[+]

Supporting Files:

No Additional Files

No Related Documents.

You May Also Like:

Detection of Ciprofloxacin-Resistant, β-Lactamase–Producing Neisseria meningitidis Serogroup Y Isolates — United States, 2019–2020

Personal Author:

McNamara, Lucy A.; Potts, Caelin; Blain, Amy E.; Retchless, Adam C.; Reese, Natashia; Swint, Stephanie; Lonsway, David; Karlsson, Maria; Lunquest, Kristy; Sweitzer, John J.; Wang, Xin; Hariri, Susan; Fox, LeAnne M.; Dhungana, Nirmala; Gabrio-Brannon, Ryan; Kyle, Jennifer; Martin, Brittany; Barnes, Meghan; Moore, Ashley; Hannagan, Susan; Keating, Page; Li, Sandy; Albertson, Justin; Fleming, Wayne; Lurie, Perrianne; Russell, Christina; Reid, Kara; Sanders, Kelsey; DeBolt, Chas; Graff, Nicholas; Lam, Esther; Hanisch, Benjamin; Taormina, Gillian;

Corporate Authors:

Antimicrobial-Resistant Neisseria meningitidis Team. National Center for Immunization and Respiratory Diseases (U.S.). Division of Bacterial Diseases.. National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of Healthcare Quality Promotion.. Maryland. Department of Health..

Published Date:

June 19 2020

Source:

MMWR Morb Mortal Wkly Rep. 69(24):735-739

Description:

Meningococcal disease is a sudden-onset, life-threatening illness caused by the bacterium Neisseria meningitidis. Prompt empiric antibiotic treatment can reduce morbidity and mortality among patients, and antibiotic prophylaxis can prevent secondary ...

File Type:

[PDF - 176.57 KB]
Detection of Ciprofloxacin-resistant, β-lactamase-producing Neisseria meningitidis Serogroup Y Isolates, United States, 2019–2020

Corporate Authors:

Centers for Disease Control and Prevention (U.S.)

Published Date:

June 18, 2020

Series:

HAN ; 433

Description:

Distributed via the CDC Health Alert NetworkJune 18, 2020, 1:00 PM ETCDCHAN-00433Meningococcal disease, which typically presents as meningitis or meningococcemia, is a life-threatening illness requiring prompt antibiotic treatment for patients and an...

File Type:

[PDF - 147.05 KB]
Panton-Valentine Leukocidin–Secreting Staphylococcus aureus Pneumonia Complicating COVID-19

Personal Author:

Duployez, Claire; Le Guern, Rémi; Tinez, Claire; Lejeune, Anne-Laure; Robriquet, Laurent; Six, Sophie; Loïez, Caroline; Wallet, Frédéric;

Published Date:

April 16 2020

Source:

Emerg Infect Dis. 26(8):1939-1941

Description:

Necrotizing pneumonia induced by Panton-Valentine leukocidin-secreting Staphylococcus aureus is a rare but life-threatening infection that has been described in patients after they had influenza. We report a fatal case of this superinfection in a you...

File Type:

[PDF - 435.95 KB]
Current trends in the acute treatment of ischemic stroke: analysis from the Paul Coverdell National Acute Stroke Program

Personal Author:

Asaithambi, Ganesh; Tong, Xin; Lakshminarayan, Kamakshi; King, Sallyann M Coleman; George, Mary G;

Published Date:

October 2019

Source:

J Neurointerv Surg. 12(6):574-578

Description:

BackgroundThe intra-arterial treatment (IAT) of acute ischemic stroke (AIS) is now evidence-based and given the highest level of recommendation among eligible patients. Using a multi-state stroke registry, we studied the trend in IAT among patients w...

File Type:

[PDF - 370.74 KB]
U.S. Compounding Pharmacy-related Outbreaks, 2001–2013—Public Health and Patient Safety Lessons Learned

Personal Author:

Shehab, Nadine; Brown, Megan N.; Kallen, Alexander J.; Perz, Joseph F.;

Published Date:

September 2018

Source:

J Patient Saf. 14(3):164-173

Description:

ObjectivesPharmacy-compounded sterile preparations (P-CSPs) are frequently relied upon in U.S. healthcare, but are increasingly being linked to outbreaks of infections. We provide an updated overview of outbreak burden and characteristics, identify d...

File Type:

[PDF - 131.12 KB]